Drug Trial Radar · NCT00300755
Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
May 2006
Primary completion
Apr 2008
Study completion Apr 2008
Sponsor
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of PfizerPfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- Nycomed
- First posted
- Mar 9, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the clinical outcomes of treatment with oral pantoprazole in children 1 through 5 years of age with endoscopically proven symptomatic GERD.
Conditions
- Gastroesophageal Reflux
Interventions
pantoprazole sodium enteric-coated spheroidDrug
Pediatric spheroids administered once daily for 8 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Weekly Gastroesophageal Reflux Disease (GERD) Symptom Scores (WGSS)Time frame: Baseline and Weeks 1, 2, 3, 4, 5, 6, 7, 8, and Final Week
Locations
43 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Mobile, Alabama
Site not named
Phoenix, Arizona
Site not named
Oakland, California
Site not named
Orange, California
Site not named
Sacramento, California
Site not named
San Diego, California
Site not named
Wilmington, Delaware
Site not named
Washington D.C., District of Columbia
Site not named
Gainesville, Florida
Site not named
Jacksonville, Florida
Site not named
Miami, Florida
Site not named
Orlando, Florida
Site not named
Pensacola, Florida
Site not named
Peoria, Illinois
Site not named
Lexington, Kentucky
Site not named
Louisville, Kentucky
Site not named
Boston, Massachusetts
Site not named
Boston, Massachusetts
Site not named
Flint, Michigan
Site not named
Southfield, Michigan
Site not named
Jackson, Mississippi
Site not named
Omaha, Nebraska
Site not named
Las Vegas, Nevada
Site not named
Egg Harbor, New Jersey
Site not named
Morristown, New Jersey
Site not named
Buffalo, New York
Site not named
New York, New York
Site not named
Oklahoma City, Oklahoma
Site not named
Danville, Pennsylvania
Site not named
Philadelphia, Pennsylvania
Site not named
Houston, Texas
Site not named
Temple, Texas
Site not named
Norfolk, Virginia
Site not named
Charleston, West Virginia
Site not named
Huntington, West Virginia
Site not named
Milwaukee, Wisconsin
Site not named
Edmonton, Alberta, Canada
Site not named
St. John's, Newfoundland and Labrador, Canada
Site not named
Hamilton, Ontario, Canada
Site not named
London, Ontario, Canada
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.